Phase 3 Osteoarthritis Trial, Recruiting NCT07371572 Sponsor: Sint Maartenskliniek Condition: Osteoarthritis
Back to Osteoarthritis

Phase 3 Osteoarthritis Trial, Recruiting

NCT07371572
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with osteoarthritis (a type of joint wear and tear) affecting the finger joints, confirmed using X-rays taken within the last 6 months and matching reported symptoms.
  • People aged 16 years or older.
  • People who have hand pain rated above 40 out of 100 on a pain scale.
  • People who have already tried at least one standard pain medication (such as anti-inflammatory gels or tablets, not including paracetamol) and found it did not work well enough.

Who may not be able to join:

  • People who have a chronic inflammatory or rheumatic disease (such as rheumatoid arthritis).
  • People who currently have an infectious disease.
  • People with a known diagnosis of osteoporosis (brittle bones).
  • People with a known diagnosis of diabetes.
  • People who have previously been diagnosed with fibromyalgia (a widespread pain condition).
  • People with a known diagnosis of myasthenia gravis (a muscle weakness condition).
  • People who have previously had surgery on their hand (for example, carpal tunnel surgery).
  • People whose other medications are flagged as interacting with the study drug by the Dutch Medication Surveillance System (confirm with trial site).
  • People who currently have a stomach or duodenal ulcer.
  • People who currently have an active infection.
  • People with liver cirrhosis (serious liver scarring).
  • People who are pregnant or breastfeeding.
  • People who are known to not respond to, or cannot tolerate, the study drug methylprednisolone.
  • People who are not able to read or write in Dutch.
  • People who have a diagnosis of epilepsy.
  • People considered to be at risk of a psychiatric disorder (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 0243659276

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Sint Maartenskliniek
Registry
ClinicalTrials.gov
Start date
28 October 2025
Est. completion
1 April 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Efficacy of intramuscular methylprednisolone acetate in reducing hand pain between baseline and week 4, compared to placebo measured on a 0-100 mm Visual Analogue Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov